Cover Image

MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS

Show other versions (1)

The mechanism of myocardial damage in diabetes mellitus is considered. The pathogenesis of myocardial fibrosis, leading to diabetic cardiomyopathy, is described in details. Management tactics aimed at the prevention of heart failure in patients with diabetes is proposed.

Saved in:

Bibliographic Details
Main Authors:	O. M. Drapkina (Author), B. B. Gegenava (Author)
Format:	Book
Published:	Столичная издательская компания, 2015-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS
by: O. M. Drapkina, et al.
Published: (2015)

A SELECTIVE ANTAGONIST OF MINERALOCORTICOID RECEPTOR EPLERENONE IN CARDIOLOGY PRACTICE
by: B. B. Gegenava, et al.
Published: (2015)

A SELECTIVE ANTAGONIST OF MINERALOCORTICOID RECEPTOR EPLERENONE IN CARDIOLOGY PRACTICE
by: B. B. Gegenava, et al.
Published: (2015)

STATINS AND THE RISK OF DIABETES MELLITUS
by: O. M. Drapkina
Published: (2015)

STATINS AND THE RISK OF DIABETES MELLITUS
by: O. M. Drapkina
Published: (2015)

Retrospective analysis of patients with diabetes mellitus type 2 and acute myocardial infarction
by: Tatiana P. Bardymova, et al.
Published: (2022)

Treatment of myocardial interstitial fibrosis in pathological myocardial hypertrophy
by: Fuyu Zhu, et al.
Published: (2022)

Features of myocardial characteristics of patients with acute ST-segment elevation myocardial infarction with diabetes mellitus as assessed by contrast-enhanced cardiac magnetic resonance imaging
by: O. V. Stukalova, et al.
Published: (2023)

Drugs for treating myocardial fibrosis
by: Zhanhong Ren, et al.
Published: (2023)

Silent myocardial infarction in women with type II diabetes mellitus and microalbuminuria
by: Elmir Omerovic, et al.
Published: (2008)

Inhospital outcomes of myocardial infarction in patients receiving direct oral anticoagulants
by: M. G. Chashchin, et al.
Published: (2023)

Myofibrillolysis and fibrosis predicts myocardial insufficiency
by: Jerzy Pacholewicz, et al.
Published: (2019)

Myocardial fibrosis in congenital heart disease
by: Blanca Gordon, et al.
Published: (2022)

1,5-Anhydroglucitol in type 2 diabetes mellitus patients with ST elevation myocardial infarction.
by: Dinara Sheryazdanova, et al.
Published: (2021)

SUBCLINICAL MYOCARDIAL INJURY OF YOUNG PATIENTS WITH TYPE1 DIABETES MELLITUS WITHOUT CARDIOVASCULAR DISEASE
by: K. Mahamat, et al.
Published: (2017)

Salvianolic acid B ameliorates myocardial fibrosis in diabetic cardiomyopathy by deubiquitinating Smad7
by: Hong Luo, et al.
Published: (2023)

EVALUATION OF LEPTIN SERUM LEVELS IN PATIENTS WITH METABOLIC SYNDROME AND LEFT VENTRICULAR MYOCARDIAL HYPERTROPHY
by: O. M. Drapkina, et al.
Published: (2018)

DIABETES MELLITUS AND CONCURRENT RENAL INSUFFICIENCY AS PROGNOSTIC INDICATORS FOR ACUTE MYOCARDIAL INFARCTION
by: Kumar Singh Avishesh
Published: (2023)

Incidence of Fetal Myocardial Hypertrophy in Mother with Diabetes Mellitus by Using Cardio-Spatiotemporal Image Correlation (STIC) M-Mode
by: Sapanont K, et al.
Published: (2023)

ATRIAL FIBROSIS IS A MORPHOLOGICAL BASIS OF ATRIAL FIBRILLATION
by: O. M. Drapkina, et al.
Published: (2015)

ATRIAL FIBROSIS IS A MORPHOLOGICAL BASIS OF ATRIAL FIBRILLATION
by: O. M. Drapkina, et al.
Published: (2015)

Follistatin Attenuates Myocardial Fibrosis in Diabetic Cardiomyopathy via the TGF-β-Smad3 Pathway
by: Yinhui Wang, et al.
Published: (2021)

Effect of Eight Weeks of Aerobic Training on Some Myocardial Fibrosis Indices in Cardiac Muscle of Diabetic Rats
by: Abolfazl Samiei, et al.
Published: (2018)

Molecular mechanisms of myocardial damage in the hypertensive rats and hypertensive rats with metabolic disorders (diabetes mellitus, atherosclerosis)
by: Igor F. Belenichev, et al.
Published: (2022)

Neuregulin-1β, Biomarkers of Inflammation and Myocardial Fibrosis in Heart Failure Patients
by: K. A. Zhbanov, et al.
Published: (2022)

New therapeutic insights into radiation-induced myocardial fibrosis
by: Cheng-Xu Ma, et al.
Published: (2019)

Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention
by: Xiaoying Yin, et al.
Published: (2023)

Estudo da freqüência de diabetes mellitus e intolerância à glicose em pacientes com fibrose cística Study of the frequency of diabetes mellitus and glucose intolerance in patients with cystic fibrosis
by: Flávia A.A. de Castro, et al.
Published: (2001)

EVALUATION OF ATRIAL CONTRACTILE FUNCTION DISORDERS AND FIBROSIS AS PREDICTORS OF CHRONIC HEART FAILURE
by: O. M. Drapkina, et al.
Published: (2015)

EVALUATION OF ATRIAL CONTRACTILE FUNCTION DISORDERS AND FIBROSIS AS PREDICTORS OF CHRONIC HEART FAILURE
by: O. M. Drapkina, et al.
Published: (2015)

New onset diabetes mellitus and cardiovascular events in Korean patients with acute myocardial infarction receiving high-intensity statins
by: Jah Yeon Choi, et al.
Published: (2021)

Gastrodin attenuates diabetic cardiomyopathy characterized by myocardial fibrosis by inhibiting the KLK8-PAR1 signaling axis
by: MingShan Zhang, et al.
Published: (2024)

Ozone Administration Reduces Myocardial Ischemia Reperfusion Injury in Streptozotocin Induced Diabetes Mellitus Rat Model
by: Gülcan MB, et al.
Published: (2024)

Quantitative Assessment of Myocardial Ischemia in Multi-Vessel Coronary Artery Disease by Multimodal Stress Echocardiography with Semi-Supine Bicycle Ergometry
by: S. N. Koretskiy, et al.
Published: (2020)

Targeting adipokines: A new strategy for the treatment of myocardial fibrosis
by: Xiaoying Han, et al.
Published: (2022)

Research Progress of Traditional Chinese Medicine in Treatment of Myocardial fibrosis
by: Chunzhen Ren, et al.
Published: (2022)

Targeting Myocardial Fibrosis-A Magic Pill in Cardiovascular Medicine?
by: Alina Scridon, et al.
Published: (2022)

OXIDATIVE STRESS AND POSSIBILITY TO CORRECT IT WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN PATIENTS WITH MYOCARDIAL INFARCTION ASSOCIATED WITH DIABETES MELLITUS TYPE 2
by: K. S. Lexina, et al.
Published: (2015)

OXIDATIVE STRESS AND POSSIBILITY TO CORRECT IT WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN PATIENTS WITH MYOCARDIAL INFARCTION ASSOCIATED WITH DIABETES MELLITUS TYPE 2
by: K. S. Lexina, et al.
Published: (2015)

ASSESSING THE LEADER TRIAL: UNDERSTANDING MYOCARDIAL INFARCTION SUBTYPES IN TYPE 2 DIABETES MELLITUS PATIENTS AND THE BENEFICIAL IMPACT OF LIRAGLUTIDE THERAPY.
by: Satish Kumar Singh
Published: (2023)